Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

108 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Molecular pathogenesis of chronic lymphocytic leukemia.
Danilov AV, Danilova OV, Klein AK, Huber BT. Danilov AV, et al. Curr Mol Med. 2006 Sep;6(6):665-75. doi: 10.2174/156652406778195008. Curr Mol Med. 2006. PMID: 17022736 Review.
A new hope: novel therapeutic approaches to treatment of chronic lymphocytic leukaemia with defects in TP53.
Shindiapina P, Brown JR, Danilov AV. Shindiapina P, et al. Among authors: danilov av. Br J Haematol. 2014 Oct;167(2):149-61. doi: 10.1111/bjh.13042. Epub 2014 Jul 21. Br J Haematol. 2014. PMID: 25040077 Review.
Dipeptidyl peptidase 2 apoptosis assay determines the B-cell activation stage and predicts prognosis in chronic lymphocytic leukemia.
Danilov AV, Danilova OV, Brown JR, Rabinowitz A, Klein AK, Huber BT. Danilov AV, et al. Exp Hematol. 2010 Dec;38(12):1167-77. doi: 10.1016/j.exphem.2010.08.008. Epub 2010 Sep 24. Exp Hematol. 2010. PMID: 20817072 Free PMC article.
Differential control of G0 programme in chronic lymphocytic leukaemia: a novel prognostic factor.
Danilov AV, Klein AK, Lee HJ, Baez DV, Huber BT. Danilov AV, et al. Br J Haematol. 2005 Feb;128(4):472-81. doi: 10.1111/j.1365-2141.2004.05346.x. Br J Haematol. 2005. PMID: 15686454
Pericardial involvement by chronic lymphocytic leukemia/small lymphocytic lymphoma.
Danilova OV, Danilov AV. Danilova OV, et al. Among authors: danilov av. Blood. 2015 Jul 16;126(3):424. doi: 10.1182/blood-2015-04-641571. Blood. 2015. PMID: 26393248 Free PMC article. No abstract available.
Role for ZAP-70 Signaling in the Differential Effector Functions of Rituximab and Obinutuzumab (GA101) in Chronic Lymphocytic Leukemia B Cells.
Skopelja-Gardner S, Jones JD, Hamilton BJ, Danilov AV, Rigby WFC. Skopelja-Gardner S, et al. Among authors: danilov av. J Immunol. 2017 Aug 15;199(4):1275-1282. doi: 10.4049/jimmunol.1602105. Epub 2017 Jul 14. J Immunol. 2017. PMID: 28710251
SYK inhibition thwarts the BAFF - B-cell receptor crosstalk and thereby antagonizes Mcl-1 in chronic lymphocytic leukemia.
Paiva C, Rowland TA, Sreekantham B, Godbersen C, Best SR, Kaur P, Loriaux MM, Spurgeon SEF, Danilova OV, Danilov AV. Paiva C, et al. Among authors: danilov av. Haematologica. 2017 Nov;102(11):1890-1900. doi: 10.3324/haematol.2017.170571. Epub 2017 Aug 24. Haematologica. 2017. PMID: 28838991 Free PMC article.
Rapid induction of apoptosis in chronic lymphocytic leukemia cells by the microtubule disrupting agent BNC105.
Bates D, Feris EJ, Danilov AV, Eastman A. Bates D, et al. Among authors: danilov av. Cancer Biol Ther. 2016;17(3):291-9. doi: 10.1080/15384047.2016.1139245. Epub 2016 Jan 30. Cancer Biol Ther. 2016. PMID: 26891146 Free PMC article.
Cyclin-Dependent Kinase Inhibitor P1446A Induces Apoptosis in a JNK/p38 MAPK-Dependent Manner in Chronic Lymphocytic Leukemia B-Cells.
Paiva C, Godbersen JC, Soderquist RS, Rowland T, Kilmarx S, Spurgeon SE, Brown JR, Srinivasa SP, Danilov AV. Paiva C, et al. Among authors: danilov av. PLoS One. 2015 Nov 25;10(11):e0143685. doi: 10.1371/journal.pone.0143685. eCollection 2015. PLoS One. 2015. PMID: 26606677 Free PMC article.
Targeting neddylation effectively antagonizes nuclear factor-κB in chronic lymphocytic leukemia B-cells.
Godbersen JC, Paiva C, Danilova OV, Berger A, Brown JR, Danilov AV. Godbersen JC, et al. Among authors: danilov av. Leuk Lymphoma. 2015 May;56(5):1566-9. doi: 10.3109/10428194.2014.990901. Leuk Lymphoma. 2015. PMID: 26086969
108 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page